Literature DB >> 15750472

Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.

Mary Ann De Groote1, Daniel N Frank, Elaine Dowell, Mary P Glode, Norman R Pace.   

Abstract

Probiotic agents are increasingly used for the treatment and prevention of a variety of infectious and inflammatory conditions. They are generally safe, but complications of probiotic use can occur. In this report, we describe bacteremia after ingestion of a Lactobacillus rhamnosus GG probiotic tablet in a child with short gut syndrome. We used sequencing of the ribosomal operon region and strain typing with pulsed field electrophoresis of the isolates to show identity between the tablet and bloodstream isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750472     DOI: 10.1097/01.inf.0000154588.79356.e6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  62 in total

1.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

2.  Probiotics for Crohn's disease: what have we learned?

Authors:  C Prantera
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

3.  Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function.

Authors:  Elaine O Petrof; Erika C Claud; Jun Sun; Tatiana Abramova; Yuee Guo; Tonya S Waypa; Shu-Mei He; Yasushi Nakagawa; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2009-10       Impact factor: 5.325

4.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

Review 5.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

6.  An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis.

Authors:  Jacob K Olson; Jason B Navarro; Jacob M Allen; Christopher J McCulloh; Lauren Mashburn-Warren; Yijie Wang; Vanessa A Varaljay; Michael T Bailey; Steven D Goodman; Gail E Besner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

7.  Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine.

Authors:  Julie Mirpuri; Jennifer C Brazil; Andrew J Berardinelli; Tala R Nasr; Kiesha Cooper; Michael Schnoor; Patricia W Lin; Charles A Parkos; Nancy A Louis
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

8.  Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus.

Authors:  Christopher D Doern; Sean T Nguyen; Folashade Afolabi; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

9.  Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study.

Authors:  Hyun Joo Song; Jin-Yong Kim; Sung-Ae Jung; Seong-Eun Kim; Hye-Sook Park; Yoolwon Jeong; Sung Pil Hong; Jae Hee Cheon; Won Ho Kim; Hyo-Jong Kim; Byong Duk Ye; Suk-Kyun Yang; Sang-Woo Kim; Sung-Jae Shin; Hyun-Soo Kim; Jae-Kyu Sung; Eun Young Kim
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

Review 10.  Microbial therapeutic interventions.

Authors:  Nicole G Grady; Elaine O Petrof; Erika C Claud
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-25       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.